Prevent Diseases: Osimertinib Mechanism of Action

Well-proven and extremely efficient

Osimertinib mechanism of action is a drug recently released to the public as a highly effective treatment for people with EGFR-mutated non-small cell lung cancer. This condition is tough to treat because many of the current therapies available have little effect on this type of cancer, which means Osimertinib could be a monumental step forward in treating this disease. Osimertinib works by blocking an essential protein called epidermal growth factor receptor (EGFR), which is found in some types of tumor cells and stimulates their uncontrolled growth. Inhibition from Osimertinib causes those cells not to grow, reproduce or spread anymore. It was discovered by AstraZeneca and initially named AZD9291.

Tailored to safeguard you and target cells that are threatening your health

In a nutshell, Osimertinib is a cancer drug that has been tailored specifically to target the EGFR protein in cells. Osimertinib mechanism of action works as a tumor suppressor. Osimertinib is used to treat non-small cell lung cancer (NSCLC). People with EGFR gene mutations who have already been treated with chemotherapy and targeted therapies are more likely to benefit from Osimertinib. Oncologists are currently prescribing it in the form of an 80mg pill taken once daily after meals or coffee/tea at least half an hour later. Additionally, Osimertinib was the first drug approved for use by the FDA in the newly diagnosed setting with EGFR mutation and T790M mutation.

Patients are comfortable with it; No harmful side effects

The Osimertinib pill is well tolerated by patients, with most adverse effects being mild to moderate. However, as with any drug, some risks are associated with taking Osimertinib.. One common side effect of Osimertinib is diarrhea. This is usually mild and goes away within a few days.

If Osimertinib causes dizziness or blurred vision, use caution when performing tasks that require alertness, such as driving a car, operating machinery, etc. Osimertinib treats metastatic non-small cell lung cancer that no longer responds to other treatments. It is also called Osimertinib mesylate salt. It works by blocking the action of an abnormal protein involved in tumor growth, stopping cancer cells from growing and dividing.

The Osimertinib mechanism of action in human plasma were determined by tandem mass spectrometry. Samples were prepared for analysis by protein precipitation with acetonitrile followed by centrifugal ultrafiltration using a YM30 Diaflo membrane device (Millipore, Billerica, Mass). The Osimertinib concentration was measured in the fraction that contained less than 30 KDA species; Osimertinib was undetectable in other fractions.

The Osimertinib concentration was determined to be 0.51 mg/L (0.14 μΜ) at a steady-state after two weeks of dosing at 80 mg daily.

Food additive Osimertinib is rapidly absorbed and extensively metabolized in humans. Osimertinib is a substrate of CYP3A4, and Osimertinib plasma concentrations are increased by inhibitors of CYP3A4 and P-glycoprotein.

Approved for commercialization by the FDA

Osimertinib tablets are indicated to treat patients with metastatic NSCLC whose tumors have EGFR T790M mutation as detected by an FDA-approved test or other investigational resistance mutations, who have disease progression on or after EGFR tyrosine kinase inhibitor therapy.

Osimertinib mechanism of action is a cancer medication that interferes with the growth and spread of cancer cells in the body. It is used to treat non-small cell lung cancer (NSCLC). People may also use Osimertinib tablet for purposes not listed in this medication guide. Osimertinib tablet comes as a tablet to take by mouth. It is usually taken once a day with or without food.

Take an Osimertinib pill at around the same time every day. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Take an Osimertinib tablet precisely as directed. Please do not take more or less of it or take it more often than prescribed by your doctor.

Conclusion

Osimertinib mechanism of action is a medicine that can be used to treat some types of cancer. Osimertinib works by blocking the growth and spread of tumor cells in your body. Osimertinib has been shown to stop or slow down certain cancers from growing, shrinking tumors, and reducing pain. Osimertinib belongs to a group of medicines called kinase inhibitors. Kinases are proteins that play an essential role in cell division and other functions within cells, such as signaling messages between different parts of the cell. Osimertinib blocks one type (EGFR) enzyme needed for many normal body processes, including controlling how fast new blood vessels form inside tumors so they can grow large enough for treatment. Osimertinib may also target other enzymes like anti-angiogenic factors (which stop blood vessel growth) and Bcl-2 (a protein that helps keep cancer cells alive). Osimertinib can be used to treat certain types of non-small cell lung cancer (NSCLC). Osimertinib is a drug that slows the disease. It reduces the growth of cancer cells.